The Blog Posts
Thrust on care of TB-infected HIV patients Stress on coordinated effort to fight TB Volunteers needed for anti-TB campaign
About Lilly
About the Lilly MDR TB partnership
The Lilly MDR-TB Partnership was created to help contain and ultimately conquer multidrug-resistant tuberculosis (MDR-TB), a disease so daunting that no single organization can fight it alone. The Partnership, a public-private initiative, mobilizes 18 partners on five continents in the battle to stop the spread of MDR-TB and save lives. Lilly is donating $135 million in cash, medicines and technology to increase access to treatment and focus global resources on prevention, diagnosis and treatment of patients with MDR-TB.
The Lilly Partnership initiatives all have one thing in common: improved care for some of the world’s most vulnerable people, who are least able to fight this disease. The public-private partnership provides access to medicines, transfers manufacturing technology to the developing world, trains healthcare workers, raises awareness and promotes research and prevention, while providing support for communities and advocating on behalf of patients. The partners work together closely, sharing knowledge, expertise and research in the quest to contain and conquer one of the world’s oldest diseases. The Lilly MDR-TB Partnership is about more than the transfer of technology and know-how — it’s the Transfer of Hope.
To know more about click www.lillymdr-tb.com
